Previous close | 0.0955 |
Open | 0.0943 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0931 - 0.0992 |
52-week range | 0.0300 - 0.1500 |
Volume | |
Avg. volume | 1,424,514 |
Market cap | 101.167M |
Beta (5Y monthly) | 0.51 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ANN ARBOR, Mich., March 28, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), comments on an exciting advancement in spider silk engineering from the Rensselaer Polytechnic Institute ("RPI"). Researchers at RPI published a paper in Microbial Cell Factories outlining a new and novel method of creating spider silk protein from waste plastics. This project used a new strain of Pseudomonas bacteria capable of converting depolymerized polyethyle
ANN ARBOR, Mich., March 19, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), announces today that Dr. Nirmal Kumar, a globally recognized expert in sericulture, will join the Company’s Senior Management in Vietnam to supervise the start of the spring production trials and the launch of the BAM-1 hybrid. Dr. Nirmal Kumar gained recognition as a leading authority in the breeding and rearing of silkworms through his 37 years of work at the Ce
ANN ARBOR, Mich., March 12, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), announces today that senior management members will travel to Vietnam this week to oversee the launch of the spring production trials and lay the groundwork for the Company's planned commercial expansion. The launch of the BAM-1 production trial is the next critical benchmark in the Company's plan for commercial-scale production of recombinant spider silk. Managem